Biolife Solutions Inc. (BLFS) intrinsic value & 10-year financials
Biolife Solutions Inc. (BLFS) has a Graham intrinsic value of $4.65 per share. Over the last 10 fiscal years revenue grew 31.4% a year to $96.2M, with an average return on invested capital of -15.7%.
- Graham intrinsic value
- $4.65
- Revenue (FY2025)
- $96.2M
- Revenue growth (10-yr CAGR)
- 31.4%
- ROIC (10-yr avg)
- -15.7%
- Free cash flow (FY2025)
- $10.6M
BLFS 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $96.2M | -$4.6M | -$0.10 | $10.6M | -17.3% | -5.2% |
| FY2024 | $82.3M | -$20.2M | -$0.44 | $5.2M | -8.7% | -2.3% |
| FY2023 | $143.3M | -$66.4M | -$1.52 | -$18.9M | -49.4% | -19.6% |
| FY2022 | $161.8M | -$139.8M | -$3.29 | -$18.9M | -90.0% | -34.3% |
| FY2021 | $119.2M | -$7.6M | -$0.20 | -$13.0M | -28.5% | -6.1% |
| FY2020 | $48.1M | $2.7M | -$0.03 | $4.7M | -11.6% | -3.4% |
| FY2019 | $27.4M | -$1.7M | -$0.09 | $538.0K | -0.8% | -0.3% |
| FY2018 | $19.7M | $3.3M | $0.14 | $1.8M | 18.5% | 12.3% |
| FY2017 | $11.0M | -$2.5M | -$0.21 | $461.4K | -9.6% | -17.6% |
| FY2016 | $8.2M | -$6.9M | — | -$4.5M | -59.0% | -80.7% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
BIOLIFE SOLUTIONS INC is a consistent compounder, expanding top-line revenue at 31.4% annually over the past decade.
BIOLIFE SOLUTIONS INC has historically struggled to out-earn its cost of capital, averaging just -18.8% ROIC.
BIOLIFE SOLUTIONS INC has not shown aggressive share repurchases (>10% retirement) or a major balance-sheet leverage increase (>50% net debt growth) over the 10-year window.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, BIOLIFE SOLUTIONS INC is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $4.65 per share.